Speak to a doctor Chat via text or video, share symptoms and goals, and ask any questions
A Skeptical Take of Semaglutide for Cardiac Protection A preventive cardiologist offers a critical appraisal of the SELECT trial of Semaglutide (Wegovy) When the New England Journal of Medicine published the placebo-controlled SELECT trial of semaglutide in patients with established vascular disease, I had thought cardiology had discovered another disease-modifying drug
The company was afraid that physicians wouldnt be able to differentiate between the risk of DKA in type 1 diabetes being 2-4% in a year, or in people with type 2 diabetes, where the risk is very, very low, Mathieu said
503B outsourcing facilities compound products on a larger scale (bulk amounts) for healthcare providers to have on hand and administer to patients in their offices
Distinguishing Between Androgenic Alopecia, Telogen Effluvium, and Alopecia Areata Hair loss can be distressing
They do not undergo the same extensive stability testing that large pharmaceutical manufacturers conduct over years of development